Published in Clin Exp Immunol on July 01, 1977
Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J Exp Med (1989) 2.32
Self tolerance and localized autoimmunity. Mouse models of autoimmune disease that suggest tissue-specific suppressor T cells are involved in self tolerance. J Exp Med (1987) 2.14
A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (1991) 1.45
Autoimmune thyroiditis: conversion of low-responder mice to high-responders by cyclophosphamide. Clin Exp Immunol (1982) 0.91
Specificity of anti-type II collagen antibody response in rats. Clin Exp Immunol (1984) 0.86
Autoantibody to liver-specific lipoprotein in the mouse: regulation by naturally occurring autoantigen specific suppressor cells. Clin Exp Immunol (1984) 0.85
Experimental autoimmune thyroiditis: modulation of the disease level in high and low responder mice by thymosin. Clin Exp Immunol (1984) 0.77
Significance of lymphocytes and blood vessel changes for edema formation in polyradiculoneuritis. Acta Neuropathol (1988) 0.75
The role of suppressor T cells in the expression of autoimmune haemolytic anaemia in NZB mice. Clin Exp Immunol (1981) 0.75
Premises for immune interventional therapy in rheumatoid arthritis. Postgrad Med J (1988) 0.75
Activation of suppressor function of human peripheral blood T cells by (+)cyanidanol-3: its application to chronic active liver diseases. Clin Exp Immunol (1983) 0.75
Experimental allergic encephalomyelitis. Inhibition of clinical signs and paradoxical enhancement of lesions in second attacks. Am J Pathol (1980) 0.75
Prevention of autoimmune thyroiditis in T cell-depleted rats by injections of crude thyroid extract. Clin Exp Immunol (1977) 0.75
Specificity of virus-immune effector T cells for H-2K or H-2D compatible interactions: implications for H-antigen diversity. Transplant Rev (1976) 8.10
Pathogenesis of chronic disease associated with persistent lymphocytic choriomeningitis viral infection. I. Relationship of antibody production to disease in neonatally infected mice. J Exp Med (1969) 6.03
Infectious immunological tolerance. Immunology (1971) 5.30
The pathogenesis of autoimmunity in New Zealand black mice. Curr Top Microbiol Immunol (1974) 3.98
Antigen binding cells in tolerance and immunity. Transplant Rev (1970) 3.08
T cell-dependent suppression of an anti-hapten antibody response. Transplant Rev (1975) 3.06
Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression. J Exp Med (1976) 3.00
Cell-to-cell interaction in the immune response. X. T-cell-dependent suppression in tolerant mice. J Exp Med (1974) 2.77
Active suppression of immunoglobulin allotype synthesis. 3. Identification of T cells as responsible for suppression by cells from spleen, thymus, lymph node, and bone marrow. J Exp Med (1973) 2.57
Spontaneous thyroiditis in thymectomized and irradiated Wistar rats. Clin Exp Immunol (1973) 2.55
Loss with age in NZB-W mice of thymic suppressor cells in the graft-vs-host reaction. J Immunol (1974) 2.45
Lymphocytes binding human thyroglobulin in healthy people and its relevance to tolerance for autoantigens. Lancet (1973) 2.28
Tolerance and contact sensitivity to DNFB in mice. 3. Transfer of tolerance with "suppressor T cells". J Immunol (1974) 2.25
Thyroiditis in T cell-depleted rats. Influence of strain, radiation dose, adjuvants and antilymphocyte serum. Clin Exp Immunol (1975) 2.22
Variable effects of anti-lymphocyte serum on humoral antibody formation: role of thymus dependency of antigen. J Immunol (1971) 1.80
Evidence for specific suppression in the maintenance of immunologic tolerance. J Exp Med (1975) 1.55
Spontaneous thyroiditis in the obese strain of chickens. IV. The effect of thymectomy and thymo-bursectomy on the development of the disease. J Immunol (1970) 1.54
Postthymectomy wasting associated with autoimmune phenomena. I. Antiglobulin-positive anemia in A and C57BL-6 Ks mice. J Exp Med (1967) 1.44
ENCEPHALITOGEN-INDUCED INHIBITION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS: PREVENTION, SUPPRESSION AND THERAPY. Ann N Y Acad Sci (1965) 1.41
Rapid breaking of tolerance against Escherichia coli lipopolysaccharide in vivo and in vitro. J Exp Med (1972) 1.40
Tolerance to an autoantigen-thyroglobulin. Antigen-binding lymphocytes in thymus and blood in health and autoimmune disease. Lancet (1973) 1.36
Separation of helper and suppressor T lymphocytes on a ficoll velocity sedimentation gradient. J Exp Med (1976) 1.36
Autoimmune murine thyroiditis. IV. Localization of genetic control of the immune response. J Immunol (1974) 1.34
Susceptibility of inbred rat strains to experimental thyroiditis: quantitation of thyroglobulin-binding cells and assessment of T-cell function in susceptible and non-susceptible strains. Clin Exp Immunol (1975) 1.33
Suppressor cell control of unresponsiveness to experimental allergic encephalomyelitis. J Immunol (1975) 1.28
Experimental autoimmune encephalomyelitis in mice: genetic control of susceptibility. J Immunogenet (1976) 1.27
Experimental allergic encephalomyelitis in inbred and outbred mice. J Immunol (1973) 1.25
Neonatal thymectomy increases spontaneous autoimmune thyroiditis. J Immunol (1973) 1.23
Dissociation of antibody production from disease suppression in the inhibition of allergic encephalomyelitis by myelin basic protein. J Immunol (1970) 1.19
T cell necessity in the pathogenesis of experimental autoimmune encephalomyelitis in mice. Eur J Immunol (1976) 1.14
Experimental autoimmune encephalomyelitis in mice: immunologic response to mouse spinal cord and myelin basic proteins. J Immunol (1975) 1.12
Adoptive transfer of the diseases of New Zealand black mice to normal mouse strains. Clin Exp Immunol (1969) 1.08
T cell suppression in vitro. II. Nature of specific suppressive factor. Eur J Immunol (1974) 1.04
Physical separation of "suppressor" from "helper" thymocytes. J Immunol (1975) 0.92
Antigen-binding lymphocytes in normal man and guinea pig to human encephalitogenic protein. J Immunol (1973) 0.92
Inhibition of in vitro cell migration in experimental allergic encephalomyelitis. J Immunol (1969) 0.92
Protective action of the encephalitogen and other basic proteins in experimental allergic encephalomyelitis. Immunochemistry (1968) 0.90
Passive transfer of experimental allergic encephalomyelitis: mechanisms of suppression. J Immunol (1969) 0.89
Antigen-induced inhibition of experimental allergic encephalomyelitis. I. Inhibition in guinea pigs injected with non-encephalitogenic modified myelin basic protein. J Immunol (1972) 0.89
Role of antibodies to galactocerebroside in experimental allergic encephalomyelitis. Immunology (1975) 0.86
Immune protection against experimental autoimmune encephalomyelitis: optimal conditions and analysis of mechanism. Cell Immunol (1974) 0.85
The abrogation of immunological tolerance by means of allogeneic confrontation. Transplant Rev (1972) 0.84
Suppression of experimental allergic encephalomyelitis by chemically modified encephalitogen. Immunochemistry (1972) 0.82
Antigen-induced inhibition of experimental allergic encephalomyelitis. II. Studies in guinea pigs with the small rat myelin basic protein. J Immunol (1973) 0.82
Tolerance induction to a heterotopic cardiac allograft in the irradiated reconstituted mouse. Transplantation (1974) 0.81
Durability of immune protection against experimental autoimmune encephalomyelitis. Cell Immunol (1976) 0.80
Antibody formation by spleen cells of immunologically tolerant mice stimulated with antigen-antibody complexes. J Immunol (1971) 0.78
Studies on auto-immune encephalomyelitis in the guinea pig. I. Influence of different immunizations on antibody specificity and biological properties, relation to the incidence of the disease. Int Arch Allergy Appl Immunol (1974) 0.77
IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J Immunol (1996) 5.38
The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science (2001) 4.89
Limited heterogeneity of rearranged T-cell receptor V alpha transcripts in brains of multiple sclerosis patients. Nature (1990) 3.30
Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. J Exp Med (2001) 2.60
TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat Med (1998) 2.42
B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions. J Immunol (1999) 2.06
Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature (1993) 2.01
IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein. Int Immunol (1998) 2.00
Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J Clin Invest (1993) 1.62
T-cell receptor V alpha and C alpha alleles associated with multiple and myasthenia gravis. Proc Natl Acad Sci U S A (1989) 1.47
Experimental autoimmune encephalomyelitis in mice: genetic control of susceptibility. J Immunogenet (1976) 1.27
Elicitation of experimental allergic encephalomyelitis (EAE) in mice with the aid of pertussigen. Cell Immunol (1984) 1.20
The structure and function of myelin oligodendrocyte glycoprotein. J Neurochem (1999) 1.20
Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein. Autoimmunity (1998) 1.20
Immunopathology of murine experimental allergic orchitis. J Immunol (1983) 1.15
T cell necessity in the pathogenesis of experimental autoimmune encephalomyelitis in mice. Eur J Immunol (1976) 1.14
T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls. J Neurosci Res (2001) 1.14
Experimental autoimmune encephalomyelitis in mice: immunologic response to mouse spinal cord and myelin basic proteins. J Immunol (1975) 1.12
Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J Immunol (1995) 1.10
Targeted expression of baculovirus p35 caspase inhibitor in oligodendrocytes protects mice against autoimmune-mediated demyelination. EMBO J (2000) 1.08
Identification of two human brain aryl sulfotransferase cDNAs. Biochem Biophys Res Commun (1993) 1.01
Detection of various forms of brain myelin basic protein in vertebrates by electroimmunoblotting. Neurochem Res (1984) 1.00
Insights into the aetiology and pathogenesis of multiple sclerosis. Immunol Cell Biol (1998) 0.99
T-cell dependence of immune response to hepatitis B antigen in mice. Nature (1975) 0.99
Perivascular T cells express the pro-inflammatory chemokine RANTES mRNA in multiple sclerosis lesions. Scand J Immunol (1997) 0.98
Binding of complement component Clq to myelin oligodendrocyte glycoprotein: a novel mechanism for regulating CNS inflammation. Mol Immunol (1997) 0.97
Susceptibility and resistance to experimental autoimmune encephalomyelitis and neuritis in the guinea pig correlate with the induction of procoagulant and anticoagulant activities. J Immunol (1984) 0.97
Antibodies to type II collagen and HLA disease susceptibility markers in rheumatoid arthritis. Arthritis Rheum (1999) 0.95
Gamma delta T cell receptor repertoire in brain lesions of patients with multiple sclerosis. J Neuroimmunol (1993) 0.93
IgG subclass switching is associated with the severity of experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein peptide in NOD mice. Cell Immunol (1999) 0.92
Macrophage procoagulant activity as a measure of cell-mediated immunity to P2 protein of peripheral nerves in the Guillain-Barré syndrome. J Neuroimmunol (1985) 0.91
Experimental autoimmune orchitis in T-cell-deficient mice. Int Arch Allergy Appl Immunol (1978) 0.91
Ontogeny of immunity in amphibians: changes in antibody repertoires and appearance of adult major histocompatibility antigens in Xenopus. Eur J Immunol (1979) 0.90
Axonal degeneration is an early pathological feature in autoimmune-mediated demyelination in mice. Microsc Res Tech (2001) 0.90
Concomitant detection of changes in myelin basic protein and permeability of blood-spinal cord barrier in acute experimental autoimmune encephalomyelitis by electroimmunoblotting. J Neuroimmunol (1985) 0.90
Antibody response in Lewis rats injected with myelin oligodendrocyte glycoprotein derived peptides. Int Immunol (1996) 0.90
Inhibition by serum of encephalitogenic activity of myelin basic protein: nature of the serum factor responsible. Cell Immunol (1975) 0.89
Experimental autoimmune encephalomyelitis. An anatomically-based explanation of clinical progression in rodents. J Neuroimmunol (1982) 0.89
Regulation of myelin oligodendrocyte glycoprotein in different species throughout development. Dev Neurosci (1997) 0.88
Active suppression of the allogeneic histocompatibility reactions during the metamorphosis of the clawed toad Xenopus. Differentiation (1980) 0.87
In vitro evidence for T-B lymphocyte collaboration in the clawed toad, Xenopus. Eur J Immunol (1980) 0.86
Genetic control of T helper cell function in the clawed toad Xenopus laevis. Eur J Immunol (1981) 0.86
Characterization of cDNA and genomic clones encoding human myelin oligodendrocyte glycoprotein. J Neurochem (1995) 0.86
Association of susceptibility to multiple sclerosis with TCR genes. Immunol Today (1992) 0.85
A conformational study of the human and rat encephalitogenic myelin oligodendrocyte glycoprotein peptides 35-55. Eur J Biochem (1997) 0.84
Changes of extracellular space volume and tortuosity in the spinal cord of Lewis rats with experimental autoimmune encephalomyelitis. Physiol Res (1996) 0.84
The epigenetics of multiple sclerosis: clues to etiology and a rationale for immune therapy. Annu Rev Neurosci (1994) 0.84
Expression, purification, and encephalitogenicity of recombinant human myelin oligodendrocyte glycoprotein. J Neurochem (1998) 0.84
Use of protein-bearing nitrocellulose as immunogen for in vitro production of monoclonal antibodies: application to myelin basic protein electrophoretically separated from a complex brain protein mixture. Immunol Lett (1987) 0.83
Demyelinating antibodies to myelin oligodendrocyte glycoprotein and galactocerebroside induce degradation of myelin basic protein in isolated human myelin. J Neurochem (1997) 0.82
Differing epitope selection of experimentally-induced and natural antibodies to a disease-specific autoantigen, the E2 subunit of pyruvate dehydrogenase complex (PDC-E2). Int Immunol (1992) 0.82
Transfer of murine experimental autoimmune encephalomyelitis and cell-mediated immunity to myelin protein is effected by Lyt-1 cells. J Neuroimmunol (1983) 0.82
Antibody to myelin basic protein in extracts of multiple sclerosis brain. Immunology (1981) 0.82
Gm allotypes and multiple sclerosis. J Immunogenet (1982) 0.81
Solubilization and characterization of moderate and high affinity histamine binding sites on human blood mononuclear cells. Mol Immunol (1987) 0.81
Do antibodies to myelin basic protein isolated from multiple sclerosis cross-react with measles and other common virus antigens? Clin Exp Immunol (1983) 0.81
Electroimmunoblotting of small peptides separated on urea-dodecyl sulphate (SUDS) gels. Application to myelin basic protein. J Immunol Methods (1988) 0.81
The development of autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein is associated with an upregulation of both proinflammatory and immunoregulatory cytokines in the central nervous system. J Interferon Cytokine Res (1998) 0.81
Quantitative electroimmunoblotting study of the calcium-activated neutral protease in human myelin. J Neurochem (1986) 0.80
Inhibition by serum of encephalitogenic activity of myelin basic protein. Int Arch Allergy Appl Immunol (1975) 0.80
Durability of immune protection against experimental autoimmune encephalomyelitis. Cell Immunol (1976) 0.80
HTLV-I sequences are not detected in peripheral blood genomic DNA or in brain cDNA of multiple sclerosis patients. Ann Neurol (1990) 0.79
Improved detection of lymphocyte membrane proteins in purified form and as a crude mixture using native and denaturing polyacrylamide gel electrophoresis by optimisation of coomassie brilliant blue and silver staining. Electrophoresis (1990) 0.79
Preparation of highly purified human myelin oligodendrocyte glycoprotein in quantities sufficient for encephalitogenicity and immunogenicity studies. Biochem Mol Biol Int (1993) 0.79
Purified antichick Thy-1 IgG abolishes intermediate and long-term memory. Physiol Behav (1993) 0.79
Multiple sclerosis brain immunoglobulins stimulate myelin basic protein degradation in human myelin: a new cause of demyelination. J Neurochem (1989) 0.78
Bcl-2 transgenic mice with increased number of neurons have a greater learning capacity. Brain Res (1999) 0.78
Comparison of the rat and mouse encephalitogenic determinants. Adv Exp Med Biol (1978) 0.78
Cell-mediated immune response to copolymer I in multiple sclerosis measured by the macrophage procoagulant activity assay. Int Immunol (1990) 0.78
Delayed and incomplete myelination in a transgenic mouse mutant with abnormal oligodendrocytes. J Neurosci Res (1997) 0.77
Human myelin/oligodendrocyte glycoprotein: a new member of the L2/HNK-1 family. J Neurochem (1993) 0.77
The effect of HLA-DRB1 disease susceptibility markers on the expression of RA. Scand J Rheumatol (1997) 0.77
Immunosusceptibility genes in rheumatoid arthritis. Hum Immunol (1996) 0.77
Influence of HLA-DR2, HLA-DPw4, and T cell receptor alpha chain genes on the susceptibility to multiple sclerosis. Int Immunol (1992) 0.77
Intrathecal administration of neutralizing antibody against Fas ligand suppresses the progression of experimental autoimmune encephalomyelitis. Biochem Biophys Res Commun (2000) 0.77
Fas has a crucial role in the progression of experimental autoimmune encephalomyelitis. Mol Immunol (1998) 0.76
Copper salicylate as an anti-inflammatory and analgesic agent in arthritic rats. Life Sci (1983) 0.76
Human myelin/oligodendrocyte glycoprotein: a new member of the L2/HNK-1 family. Schweiz Arch Neurol Psychiatr (1993) 0.76
Epidermal growth factor inhibits the expression of myelin basic protein in oligodendrocytes. J Neurosci Res (1989) 0.76
Inhibition of memory in the chick using a monoclonal anti-Thy-1 antibody. J Neuroimmunol (1987) 0.76
Survival and tissue localization of xenogeneic human lymphocytes in hypothymic nude mice: observations in normal subjects and multiple sclerosis. Clin Exp Immunol (1984) 0.75
DNA vaccines for the treatment of autoimmune disease. Immunol Cell Biol (1997) 0.75
Molecular detection of interferon-alpha expression in multiple sclerosis brain. J Neuroimmunol (1993) 0.75
Limited heterogeneity of rearranged T-cell receptor V alpha transcripts in brains of multiple sclerosis patients. Nature (1991) 0.75
Purification of histamine receptor proteins from detergent-solubilized human peripheral blood mononuclear cells. Biochemistry (1994) 0.75
Developmental study of myelin basic protein variants in various regions of pig nervous system. J Neurochem (1989) 0.75
Inhibition by serum of autoimmune aspermatogenic orchitis. Aust J Exp Biol Med Sci (1975) 0.75
Experimental autoimmune encephalomyelitis in mice: antigen binding lymphocytes to basic protein of myelin in susceptible and resistant strains. J Immunogenet (1977) 0.75
Anti-T cell activity of niridazole in experimental autoimmune encephalomyelitis. Int Arch Allergy Appl Immunol (1977) 0.75
Selective inhibition of the induction phase of delayed type hypersensitivity in mice by niridazole. Clin Immunol Immunopathol (1981) 0.75
A nondenaturing vertical isoelectric focusing polyacrylamide slab gel system suitable for silver staining and electrophoretic blotting. Anal Biochem (1988) 0.75
Binding properties of radiolabeled basic protein of myelin: reassessment in relation to diagnostic immunoassays. Scand J Immunol (1977) 0.75
Improved detection of the histamine receptor on human peripheral blood mononuclear cells by crosslinking using tritiated as compared with radioiodinated histamine. Electrophoresis (1990) 0.75
Incomplete Freund's adjuvant enhances locomotor performance following spinal cord injury. Eur J Neurol (2005) 0.75
A search for the "multiple sclerosis virus"--lack of effect of brain extracts on myelin development in chickens, mice and rats. Adv Exp Med Biol (1978) 0.75
Hind-limb motor ability in Lewis rats during the onset and recovery phases of experimental autoimmune encephalomyelitis. Brain Res (1981) 0.75
The New York City-HIP contract. J Natl Med Assoc (1979) 0.75
Localization of genetic control in mice over response to liver-specific F antigen. Tissue Antigens (1978) 0.75